$25.900
-0.860 (-3.32%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NAMS por análisis de gráficos similares
Alphio's NAMS stock price prediction model matches the current NewAmsterdam Pharma Company NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.79 (-0.42%). The 1-week path is $27.01 (+4.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma is currently not a strong buy due to its recent performance and financial losses, despite a positive analyst outlook. The current price is $25.9, with a significant year-to-date change of -26.42%. The RSI is at 27.88, indicating it is oversold, which could suggest a potential rebound. However, the company reported a widening net loss of $64.1 million in Q2, which raises concerns about its financial health. The main risk is the ongoing revenue decline, with an 80.7% year-over-year drop in Q2 revenue, which could hinder recovery efforts.
NAMS cerró en $25.90 el Friday, tras bajar -3.32%
NewAmsterdam Pharma Company NV (NAMS) last closed at $25.9, losing -3.32%. These facts feed the 1-day and 1-week NAMS price prediction above.
Factores de la previsión
Los factores de la previsión de NewAmsterdam Pharma Company NV (NAMS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NAMS, ordenadas por similitud.
Análisis de estacionalidad de NAMS
Historically the probability of a positive August return for NAMS is 34.92%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NAMS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $38.53 | $38.75 | $43.55 | +49.61% |
| Sep 2026 | $36.68 | $41.26 | $44.89 | +59.31% |
| Oct 2026 | $24.81 | $32.88 | $41.42 | +26.94% |
| Nov 2026 | $33.96 | $41.82 | $49.82 | +61.46% |
| Dec 2026 | $33.82 | $41.16 | $42.47 | +58.91% |
En 2026, se proyecta que NewAmsterdam Pharma Company NV (NAMS) oscile entre $24.81 y $49.82.
Previsión mensual de NewAmsterdam Pharma Company NV para 2026
En Aug de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $38.75, con un mínimo de $38.53 y un máximo de $43.55.
En Sep de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.26, con un mínimo de $36.68 y un máximo de $44.89.
En Oct de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $32.88, con un mínimo de $24.81 y un máximo de $41.42.
En Nov de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.82, con un mínimo de $33.96 y un máximo de $49.82.
En Dec de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.16, con un mínimo de $33.82 y un máximo de $42.47.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.